Covered recipient · General Payments record
BRANDON ESTEBAN BOURGEOIS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2025
$429.47
- Reported across 14 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $429.47 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MDD US Operations, LLC | $121.86 | 1 |
| GE HEALTHCARE | $84.83 | 3 |
| Teva Pharmaceuticals USA, Inc. | $43.98 | 2 |
| PFIZER INC. | $43.04 | 2 |
| Aucta Pharmaceuticals, Inc. | $25.74 | 1 |
| Amgen Inc. | $24.64 | 1 |
| Neurelis, Inc. | $22.43 | 1 |
| Janssen Biotech, Inc. | $22.31 | 1 |
| EISAI INC. | $21.67 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.97 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $429.47 | 14 |
Payment records · PY2025 (14)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $24.64 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229532441 | CMS |
| Aucta Pharmaceuticals, Inc. | $25.74 | 08/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1253619142 | CMS |
| Eisai Inc. | $21.67 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244525875 | CMS |
| GE HEALTHCARE | $35.19 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244294843 | CMS |
| GE HEALTHCARE | $24.05 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244295723 | CMS |
| GE HEALTHCARE | $25.59 | 07/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244292231 | CMS |
| Janssen Biotech, Inc. | $22.31 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175235693 | CMS |
| MDD US Operations, LLC | $121.86 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241866892 | CMS |
| Neurelis, Inc. | $22.43 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219205832 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.97 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227599692 | CMS |
| PFIZER INC. | $22.81 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230274581 | CMS |
| PFIZER INC. | $20.23 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230308292 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.06 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247453142 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.92 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247453190 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.